Protagonist Therapeutics, Inc. (PTGX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -48.94M | -36.98M | -1.94M | -28.78M | 125.36M | -29.18M | -27.86M | 268.62M | -27.43M | 16.96M | -26.61M | -26.24M | -34.35M | -31.64M | -25.2M | -13.63M | -37.67M | -26.94M | -28.47M | -23.7M |
| Operating CF Margin % | - | -497.18% | -41.11% | -518.93% | 442.65% | -17.1% | -596% | 6446.41% | -10.76% | 28.27% | - | - | - | - | - | -1587.31% | -146.44% | -312.63% | -276.78% | -1046.36% |
| Operating CF Growth % | -139.04% | -26.72% | 93.05% | -110.71% | 557.05% | -272.04% | -4.7% | 1123.79% | 20.14% | 153.61% | -5.59% | -92.43% | 8.81% | -17.43% | 11.48% | 42.47% | -30.98% | -42.78% | -74.8% | -10.32% |
| Net Income | 3.78M | 85.77M | -39.34M | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M | -33.8M | -30.84M |
| Depreciation & Amortization | 407K | -904K | 361K | 304K | 239K | 536K | 647K | 892K | 820K | 832K | 827K | 821K | 832K | 840K | 853K | 843K | 833K | 819K | 704K | 628K |
| Stock-Based Compensation | 14.52M | 10.7M | 0 | 10.91M | 13.8M | 9.09M | 10.16M | 0 | 0 | 6.6M | 6.76M | 8.34M | 7.58M | 5.51M | 5.95M | 6.8M | 5.93M | 5.02M | 4.78M | 3.94M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -67.65M | -129.87M | 8.98M | -1.35M | -1.72M | -2.76M | -2.84M | 7.28M | 7.74M | -1.35M | -1.01M | -960K | -1.06M | -914K | -89K | 96K | 358K | 509K | 500K | 473K |
| Working Capital Changes | 0 | -2.67M | 28.06M | -3.88M | 124.69M | -167.72M | -2.63M | 291.06M | -243.33M | -16.46M | 908K | 4.02M | -7.98M | -2.88M | -683K | 19.66M | -23.86M | 3.62M | -645K | 2.1M |
| Change in Receivables | 0 | 462K | -583K | 538K | 165M | -165M | 43K | 300M | -290.04M | -10M | 39K | 12K | -41K | 82K | 2.64M | 25.11M | -23.58M | 151K | 5.27M | -4.01M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12K | 41K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3M | -307K | 2.42M | 375K | 1.24M | -1.43M | -355K | -201K | 2.83M | -597K | -3.2M | 552K | 381K | -1.08M | 3.26M | -6.04M | 5.56M | 895K | -17.43M | 5.22M |
| Cash from Investing | 90.89M | 48.81M | -58.55M | 54.81M | -94.4M | -8.72M | -208.71M | -88.12M | 6.07M | -61.29M | -13.56M | 25.76M | 9.83M | 3.94M | 57.27M | 34.73M | -4.48M | 27.87M | -44.71M | 7.77M |
| Capital Expenditures | -215K | 1.45M | -88K | -813K | -545K | -310K | -775K | -28K | -242K | -19K | -404K | -176K | -10K | -70K | -162K | -290K | -273K | -196K | -265K | -500K |
| CapEx % of Revenue | - | 19.44% | 1.87% | 14.66% | 1.92% | 0.18% | 16.58% | 0.67% | 0.09% | 0.03% | - | - | - | - | - | 33.76% | 1.06% | 2.27% | 2.58% | 22.08% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.94M | -9.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -49.32M | 0 | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.94M | 9.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 23.37M | 2.84M | 5.66M | 2.92M | 11.44M | 4.03M | 12.05M | 2.57M | 7.2M | 527K | 35.31M | 108.17M | 26.46M | 553K | 680K | 680K | 16.93M | 2.17M | 1.38M | 125.39M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 2.84M | 5.66M | 2.92M | 11.92M | 0 | 12.05M | 2.57M | 7.8M | 8K | -78K | 107.87M | 24.3M | 0 | 682K | 680K | 14.55M | -166K | 1.38M | 124M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 23.37M | 0 | 0 | 0 | -479K | 4.03M | 0 | 0 | -600K | 519K | 35.39M | 304K | 2.16M | 553K | -2K | 0 | 2.37M | 2.34M | 0 | 1.4M |
| Net Change in Cash | 65.32M | 14.68M | -54.83M | 28.95M | 42.4M | -33.87M | -224.52M | 183.07M | -14.16M | -43.8M | -4.86M | 107.7M | 1.94M | -27.07M | 32.58M | 21.76M | -25.19M | 3.12M | -71.87M | 109.41M |
| Free Cash Flow | -49.16M | -35.53M | -2.02M | -29.59M | 124.82M | -29.49M | -28.64M | 268.59M | -27.67M | 16.94M | -27.02M | -26.41M | -34.36M | -31.7M | -25.36M | -13.93M | -37.94M | -27.14M | -28.73M | -24.2M |
| FCF Margin % | - | -477.73% | -42.98% | -533.59% | 440.73% | -17.28% | -612.58% | 6445.74% | -10.85% | 28.23% | - | - | - | - | - | -1621.07% | -147.5% | -314.9% | -279.36% | -1068.43% |
| FCF Growth % | -139.38% | -20.49% | 92.93% | -111.02% | 551.08% | -274.06% | -6.01% | 1116.86% | 19.46% | 153.43% | -6.51% | -89.69% | 9.44% | -16.84% | 11.73% | 42.46% | -31.3% | -42.88% | -75.62% | -11.96% |
| FCF per Share | -0.70 | -0.56 | -0.03 | -0.47 | 1.98 | -0.44 | -0.46 | 4.38 | -0.44 | 0.27 | -0.46 | -0.47 | -0.68 | -0.64 | -0.52 | -0.28 | -0.78 | -0.56 | -0.60 | -0.54 |
| FCF Conversion (FCF/Net Income) | -12.94x | 0.83x | 0.05x | 0.83x | -10.76x | -0.22x | 0.84x | -8.77x | -0.13x | 0.62x | 0.78x | 0.68x | 1.02x | 0.93x | 0.81x | 0.33x | 1.80x | 0.73x | 0.84x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |